Wednesday , December 8 2021

Lung cancer, the deadliest and one with the least attention


The lung cancer is a neoplastic disease more deadly in Latin America and the one that gets less attention from the health sector, she discovered the study "Lung cancer in Latin America: it's time to stop looking at another way", conducted by The Economist Intelligence Unit (EIU).

In the study, presented at the Congress of the Mexican Society for Oncology (SMEO), data from 12 Latin American countries were analyzed, indicating that 99% of cases in Mexico lung cancer is diagnosed in the third or fourth phase, while in other countries of the region the rate is 85%.

Irene Mia, global editor in the EIU, said that there was no record of this type of cancer
Sufficient data in the Latin America region, so we worked on identifying three priority areas in health policies for cancer control: tobacco control, access and early diagnosis.

Health experts working in the research found that the stigma about this type of cancer barrier that prevents the commitment of more specific policies and resources to other types of cancer.

"It is believed that the patients who smoked had a disease," said Dr. Oscar Arrieta, head of the lung unit of the National Cancer Institute (INCan), and emphasized that smoking is an addiction in which the Mexican state "not He has done enough to prevent."

Although smoking is still a major cause
lung cancer, 40% is due to unrelated causes, such as the presence of arsenic in water, air pollution and the use of fuel wood as fuel in kitchens.

In Mexico, this type of cancer is not covered by Seguro Popular, which covers more than 40% of the population that does not have private insurance or social security, which contributes to positioning the country at low levels in the country. tobacco control, access and early diagnosis.

In Latin America, 60,000 people die of lung cancer each year, while in Mexico 10,000 new cases are diagnosed in 2010, and according to Arrieta, by 2025, it is expected that the number will be doubled to 20,000. that "mortality will be very similar".

Ricardo Perez Cuevas, director of research at the National Institute of Public Health, said the study reflects challenges to improve prevention, diagnosis and treatment of lung cancer, and there is no unique answer to problems associated with it in Latin America. Latina

Perez Cuevas commented that Mexico's INCan, the Mexican Health Foundation and the National Institute of Public Health are working on a cost-based proposal
fight against lung cancer and smoking, which will be presented to the Mexican authorities.

"We hope that the policy for the protection against lung cancer is stable, has the necessary background and we can progress in the approach and treatment efficiency," the expert concluded.

In this note:

Source link